[1] |
CHEN Yan, ZHU Lijun, FANG Zhengmei, ZHU Hui, JIN Yuelong, SHEN Chong, YAO Yingshui.
Association of insulin-like growth factor(IGF)-1 polymorphisms and efficacy of antihypertensive drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(2): 171-179.
|
[2] |
CHEN Tao, YAN Yongxing, SHEN Yonghui.
Application of serum B type natriuretic peptide precursor and blood pressure variability in patients with non-cardiogenic ischemic stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(5): 570-573.
|
[3] |
CHEN Yong-fei, SHAO Hua, YU Feng.
Research progress of glucagon-like peptide-1 and analogues on blood pressure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(2): 228-233.
|
[4] |
HUANG Yao-hua, TANG Xin-ran, WANG Yang, ZHAO Yan-yan, LI Wei.
Application of SAS procedures in evaluation of trough/peak ratio in ambulatory blood pressure monitoring
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(11): 1246-1250.
|
[5] |
YIN Fang, LI Yun-fei, HUANG Ji-han, LI Lu-jin, ZHENG Qing-shan.
A example introduce: clinical design and quantitative evaluation of ambulatory blood pressure monitoring for once daily antihypertensive drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(6): 666-671.
|
[6] |
SUN Xiao-lei, GUAN Jun, YU Zhong-xiang, WANG Shao-hua, YAN Mei-xing, LIU Hua-qiang.
Effects of bisoprolol with different drug administration time on the blood pressure of non-dippers hypretension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(3): 292-296.
|
[7] |
WU Yan.
Clinical investigation of ACE inhibitor combined with calcium antagonist on the patients with mild to moderate essential hypertension and it's effect on the serum uric acid level
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(3): 317-321.
|
[8] |
MI Qing-xian, ZHANG Ming-sheng.
Hypotensive effect and its mechanism of taurine in fructose-induced hypertension rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(2): 160-164.
|
[9] |
XU Lin-yong, ZHANG Wei, ZENG Fang, FU Chen-chao, ZHAO Li, ZHAO Xiao-hua, SUN Zhen-qiu.
Auto statistical report for trough/peak ratio index in the evaluation of ambulatory blood pressure monitoring by SAS software
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(7): 798-802.
|
[10] |
CAO Jin-xiu, ZHANG Li-ping, GAO Chun-lin, JIA Jun-ya.
Patho-physiological function of activiated renal renin-angiotensin system in hypertension and kidney disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(12): 1436-1440.
|
[11] |
FENG Yu, YANG Lin, DAI De-zai, ZHANG Can, DAI Yin.
Comparison of inhibitory effects of CPU-86017 and its optical derivates on mouse blood pressure and rat aortic contraction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(1): 23-27.
|
[12] |
LUAN Xu.
Clinical observation and research of angiotensin converting enzyme inhibitor and angiotensin Ⅱ antagonist on diabetic renopathy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(6): 706-708.
|
[13] |
LIU Xiao-yu, WU Dang-fang, ZHOU Yan, LI Jie, ZHANG Yan-hai.
Change of decreasing blood pressure on pain threshold of spontaneously hypertensive rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(4): 474-476.
|
[14] |
CAI Ping, HONG Hua-shan, WANG Yi-bo.
Relationship between different level of blood pressure and incidence of cerebral complication in patients with essential hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(9): 1030-1032.
|
[15] |
SUI Yu-xia, SUN An-sheng, YU Li-mei, WU Qin, HUANG Xie-nan, SHI Jing-shan, YUAN Mu.
Effects of naftopidil's ramification-BWYJ on blood pressure in rat and haemodynamics in cats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(8): 852-856.
|